Midatech Pharma Plc A részvények lebegnek
Mi az Midatech Pharma Plc A részvények lebegnek?
A A részvények lebegnek az Midatech Pharma Plc - 85.470M 134.85%
Mi a A részvények lebegnek meghatározása?
Részvények úszó az a része, a vállalat részvényeinek, hogy a kezében az állami befektetők, szemben a bezárt raktáron.
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
A részvények lebegnek a Health Care szektor a LSE-on cégekben a Midatech Pharma Plc -hoz képest
Mit csinál Midatech Pharma Plc?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
a részvények lebegnek -hoz hasonló cégek Midatech Pharma Plc
- Manali Petrochemicals nak A részvények lebegnek 85.272M 49.58% van
- Progressive Path nak A részvények lebegnek 85.301M 8.22% van
- The Real Brokerage Inc nak A részvények lebegnek 85.341M 47.90% van
- ITD Cementation India nak A részvények lebegnek 85.408M 49.72% van
- Asahi India Glass nak A részvények lebegnek 85.419M 35.14% van
- iTech Minerals Ltd nak A részvények lebegnek 85.461M 72.13% van
- Midatech Pharma Plc nak A részvények lebegnek 85.470M 134.85% van
- Atlantic Power nak A részvények lebegnek 85.470M 95.27% van
- Manali Petrochemicals nak A részvények lebegnek 85.519M 49.72% van
- Select Sands nak A részvények lebegnek 85.545M 96.59% van
- Greenlane Renewables nak A részvények lebegnek 85.552M 64.60% van
- Kleos Space S.A nak A részvények lebegnek 85.562M 47.93% van
- Doman Building Materials nak A részvények lebegnek 85.563M 98.70% van